DE
Therapeutic Areas
Panaxia Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Panaxia Sublingual Tablet | Chronic Pain, Spasticity | Commercial |
| Panaxia Vaporizer Extract | Nausea, Appetite Stimulation | Commercial |
| Panaxia Suppository | Severe Nausea, Pain | Commercial |
Leadership Team at Panaxia
DD
Dr. Dadi Segal, Ph.D
CEO & Founder
AR
Assi Rotbart
General Manager
SB
Sigal Ben Eli
CFO
JK
Jonathan Kolber
Board Chairman
PA
Prof. Aaron Ciechanover
Scientific Advisor
PD
Prof. David (Dedi) Meiri
Scientific Advisor
PM
Prof. Markus Veit, Ph.D
Scientific Advisor
DN
Dr. Noa Leibobvitch
Product Development Lead